|12.02||+0.45 / +3.89%|
Data as of 4:00pm ET
|12.02||0.00 / 0.00%|
The 7 analysts offering 12-month price forecasts for Durata Therapeutics Inc have a median target of 14.00, with a high estimate of 19.00 and a low estimate of 10.00. The median estimate represents a +16.47% increase from the last price of 12.02.
The current consensus among 7 polled investment analysts is to Buy stock in Durata Therapeutics Inc. This rating has held steady since November, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.